13F reference period
Q2 2026
Security Snapshot
TENET HEALTHCARE CORP - Common Stock (THC) Institutional Ownership
CUSIP: 88033G407
13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026
Institutions Reporting
684
Shares (Excl. Options)
80.19M
Full value: 80,191,779 · shares · 30 Jun 2026Price
$187.08
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- THC on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 80,191,779
- Total 13F value
- $15,005,985,524
- Portfolio coverage rank
- 0.01%
- Share change
- -1,743,792
- Value change
- -$331,782,333
- Number of holders
- 684
- Shares outstanding
- 80,838,300
- SEC-reported price per share
- $268.76
- Insider filing price
- $268.76
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- THC - TENET HEALTHCARE CORP - Common Stock is tracked under CUSIP 88033G407.
- 684 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 695 to 684 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$15.48B
Full value: $15,480,940,272 · USD · 31 Mar 2026.$15.01B
Full value: $15,005,985,524 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 684 institutions filings for Q2 2026.
Security key
88033G407
13F reference period
Q2 2026
13F holders
684
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
THC full holder history
TENET HEALTHCARE CORP SEC filings
TENET HEALTHCARE CORP company facts
TENET HEALTHCARE CORP insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 88033G407:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
THC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 10% | +13% | $2,101,229,932 | -$79,975,522 | 8,083,830 | -3.7% | BlackRock, Inc. | 31 Aug 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 9.2% | $1,640,783,037 | 7,954,926 | T. Rowe Price Associates, Inc. | 30 Jun 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.3% | $864,671,673 | 4,582,013 | Vanguard Capital Management | 31 Mar 2026 | |||
| Invesco Ltd. | 4.4% | $509,469,088 | 4,172,556 | Invesco Ltd. | 31 Mar 2025 | |||
| FMR LLC | 4.6% | $823,914,932 | 3,994,545 | FMR LLC | 30 Jun 2026 |
As of 30 Jun 2026,
684
institutional investors reported holding
shares of
TENET HEALTHCARE CORP - Common Stock (THC).
This represents
99%
of the company’s total
outstanding shares.
80.19M
Full value: 80,191,779 · shares · 30 Jun 202680.84M
Full value: 80,838,300 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
72%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | 8,743,005 | +0.44% | 0.02% | $1,635,641,325 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 9.8% | 7,957,449 | +5.8% | 0.15% | $1,488,680,000 |
| Boston Partners | 5.5% | 4,433,360 | +16% | 0.74% | $829,063,147 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.2% | 4,238,108 | -1.8% | 0.04% | $792,865,245 |
| FMR LLC | 4.9% | 3,994,545 | -49% | 0.03% | $747,299,553 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.8% | 3,894,189 | -0.44% | 0.02% | $728,524,878 |
| STATE STREET CORP | 3.4% | 2,751,290 | +1.3% | 0.02% | $514,711,333 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 2.8% | 2,235,666 | +47% | 8.4% | $418,248,395 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,884,982 | -2.4% | 0.02% | $352,719,448 |
| CITADEL ADVISORS LLC | 2.2% | 1,765,596 | +322% | 0.19% | $330,307,700 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.1% | 1,708,453 | +154% | 0.14% | $319,617,387 |
| AMERIPRISE FINANCIAL INC | 2.1% | 1,664,068 | +12% | 0.06% | $311,455,335 |
| DIMENSIONAL FUND ADVISORS LP | 1.8% | 1,450,408 | +21% | 0.05% | $271,349,653 |
| Invesco Ltd. | 1.8% | 1,416,948 | -21% | 0.02% | $265,082,632 |
| VICTORY CAPITAL MANAGEMENT INC | 1.5% | 1,237,915 | +61% | 0.13% | $231,589,138 |
| NORGES BANK | 1.5% | 1,214,240 | 0.02% | $227,160,019 | |
| AQR CAPITAL MANAGEMENT LLC | 1.3% | 1,067,556 | -26% | 0.07% | $198,266,419 |
| ALLIANCEBERNSTEIN L.P. | 1.1% | 910,270 | +30% | 0.06% | $171,777,052 |
| MANNING & NAPIER ADVISORS LLC | 1.1% | 901,645 | 2.2% | $168,760,895 | |
| BANK OF AMERICA CORP /DE/ | 1.1% | 854,858 | +11% | 0.01% | $159,926,924 |
| MORGAN STANLEY | 1% | 831,612 | +4.5% | 0.01% | $155,578,325 |
| T. Rowe Price Investment Management, Inc. | 0.98% | 793,887 | +321% | 0.1% | $148,521,000 |
| NORTHERN TRUST CORP | 0.97% | 781,265 | -0.51% | 0.02% | $146,159,056 |
| Pentwater Capital Management LP | 0.95% | 765,000 | +512% | 1.1% | $143,116,200 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.8% | 646,593 | -0.82% | 0.02% | $120,964,619 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 4,167,255 | $1,065,514,076 | -$59,322,049 | $255.56 | 295 |
| 2026 Q2 | 80,191,779 | $15,005,985,524 | -$331,782,333 | $187.08 | 684 |
| 2026 Q1 | 82,011,189 | $15,480,940,272 | -$472,460,970 | $188.71 | 695 |
| 2025 Q4 | 84,556,105 | $16,805,308,136 | +$194,480,900 | $198.72 | 703 |
| 2025 Q3 | 83,524,934 | $16,956,383,383 | -$548,485,967 | $203.04 | 673 |
| 2025 Q2 | 86,705,205 | $15,256,042,920 | -$242,114,800 | $176.00 | 619 |
| 2025 Q1 | 88,102,608 | $11,848,580,868 | -$297,990,635 | $134.50 | 557 |
| 2024 Q4 | 90,782,644 | $11,460,937,238 | +$74,973,470 | $126.23 | 571 |
| 2024 Q3 | 88,853,987 | $14,755,648,870 | -$388,930,023 | $166.20 | 596 |
| 2024 Q2 | 92,054,252 | $12,246,548,506 | -$231,494,763 | $133.03 | 522 |
| 2024 Q1 | 93,979,649 | $9,878,072,066 | +$21,023,735 | $105.11 | 448 |
| 2023 Q4 | 95,052,239 | $7,183,420,124 | -$61,999,835 | $75.57 | 420 |
| 2023 Q3 | 96,023,570 | $6,326,878,906 | -$70,153,915 | $65.89 | 405 |
| 2023 Q2 | 95,766,096 | $7,793,537,068 | -$238,287,442 | $81.38 | 410 |
| 2023 Q1 | 99,389,967 | $5,903,975,587 | -$260,800,223 | $59.42 | 359 |
| 2022 Q4 | 104,685,581 | $5,107,056,484 | -$189,448,183 | $48.79 | 349 |
| 2022 Q3 | 107,996,779 | $5,568,387,416 | +$91,465,890 | $51.58 | 346 |
| 2022 Q2 | 105,740,110 | $5,559,583,262 | -$63,755,091 | $52.56 | 347 |
| 2022 Q1 | 105,282,868 | $9,052,535,353 | +$282,827,156 | $85.96 | 388 |
| 2021 Q4 | 102,521,862 | $8,374,229,051 | +$119,235,986 | $81.69 | 361 |
| 2021 Q3 | 100,968,332 | $6,709,151,477 | +$55,798,127 | $66.44 | 326 |
| 2021 Q2 | 100,293,045 | $6,718,584,522 | +$246,651,010 | $66.99 | 314 |
| 2021 Q1 | 97,408,920 | $5,065,644,752 | -$60,322,413 | $52.00 | 299 |
| 2020 Q4 | 99,122,344 | $3,958,107,321 | -$64,323,227 | $39.93 | 264 |
| 2020 Q3 | 102,234,584 | $2,504,131,936 | +$7,053,786 | $24.51 | 234 |